Creative Planning’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-13,500
| Closed | -$55K | – | 2727 |
|
|
2021
Q1 | $55K | Hold |
13,500
| – | – | ﹤0.01% | 2341 |
|
|
2020
Q4 | $54K | Hold |
13,500
| – | – | ﹤0.01% | 2095 |
|
|
2020
Q3 | $36K | Hold |
13,500
| – | – | ﹤0.01% | 1934 |
|
|
2020
Q2 | $37K | Hold |
13,500
| – | – | ﹤0.01% | 1787 |
|
|
2020
Q1 | $32K | Hold |
13,500
| – | – | ﹤0.01% | 1682 |
|
|
2019
Q4 | $63K | Hold |
13,500
| – | – | ﹤0.01% | 1802 |
|
|
2019
Q3 | $45K | Hold |
13,500
| – | – | ﹤0.01% | 1803 |
|
|
2019
Q2 | $44K | Sell |
13,500
-53
| -0.4% | -$153 | ﹤0.01% | 1827 |
|
|
2019
Q1 | $41K | Hold |
13,553
| – | – | ﹤0.01% | 1793 |
|
|
2018
Q4 | $37K | Sell |
13,553
-1,141
| -8% | -$3.76K | ﹤0.01% | 1742 |
|
|
2018
Q3 | $49K | Buy |
14,694
+941
| +7% | +$2.91K | ﹤0.01% | 1882 |
|
|
2018
Q2 | $35K | Buy |
13,753
+253
| +2% | +$630 | ﹤0.01% | 1874 |
|
|
2018
Q1 | $30K | Hold |
13,500
| – | – | ﹤0.01% | 1865 |
|
|
2017
Q4 | $27K | Sell |
13,500
-10,000
| -43% | -$21.8K | ﹤0.01% | 1840 |
|
|
2017
Q3 | $76K | Sell |
23,500
-3,000
| -11% | -$9.26K | ﹤0.01% | 1744 |
|
|
2017
Q2 | $85K | Hold |
26,500
| – | – | ﹤0.01% | 2110 |
|
|
2017
Q1 | $75K | Hold |
26,500
| – | – | ﹤0.01% | 2155 |
|
|
2016
Q4 | $62K | Sell |
26,500
-800
| -3% | -$1.52K | ﹤0.01% | 2218 |
|
|
2016
Q3 | $46K | Hold |
27,300
| – | – | ﹤0.01% | 2433 |
|
|
2016
Q2 | $29K | Hold |
27,300
| – | – | ﹤0.01% | 2529 |
|
|
2016
Q1 | $24K | Buy |
27,300
+5,000
| +22% | +$4.84K | ﹤0.01% | 2637 |
|
|
2015
Q4 | $27K | Buy |
22,300
+17,300
| +346% | +$24.1K | ﹤0.01% | 2625 |
|
|
2015
Q3 | $9K | Buy |
+5,000
| New | +$9.8K | ﹤0.01% | 3285 |
|
|
2015
Q2 | – | Sell |
-5,000
| Closed | -$14K | – | 3331 |
|
|
2015
Q1 | $14K | Hold |
5,000
| – | – | ﹤0.01% | 3001 |
|
|
2014
Q4 | $13K | Hold |
5,000
| – | – | ﹤0.01% | 2975 |
|
|
2014
Q3 | $9K | Buy |
5,000
+2,800
| +127% | +$6.11K | ﹤0.01% | 3026 |
|
|
2014
Q2 | $6K | Sell |
2,200
-24,000
| -92% | -$72.2K | ﹤0.01% | 3148 |
|
|
2014
Q1 | $92K | Buy |
26,200
+24,000
| +1,091% | +$106K | ﹤0.01% | 1455 |
|
|
2013
Q4 | $10K | Sell |
2,200
-3,146
| -59% | -$12.8K | ﹤0.01% | 2574 |
|
|
2013
Q3 | $22K | Buy |
5,346
+2,646
| +98% | +$11.6K | ﹤0.01% | 2045 |
|
|
2013
Q2 | $11K | Buy |
+2,700
| New | +$10.4K | ﹤0.01% | 2244 |
|
Other funds holding ATRS
RCMNY
SIG
N
FWSM
Creative Planning's ATRS Position: Q2 2021 in Review
Creative Planning sold out of Antares Pharma, Inc. (ATRS) in Q2 2021, closing a stake of 13,500 shares — an estimated $55K sold.
Creative Planning first reported a position in ATRS in Q2 2013 and held it in 31 quarters. The position peaked at $92K in Q1 2014. 175 funds tracked by Wall St. Rank hold ATRS as of Q2 2021.
- Creative Planning reported no remaining Antares Pharma, Inc. position as of Q2 2021 after selling out during the quarter.
- Creative Planning sold 13,500 Antares Pharma, Inc. shares in Q2 2021, an estimated $55K.
- Creative Planning first reported a position in Antares Pharma, Inc. in Q2 2013 and held it in 31 quarters.
- Creative Planning's Antares Pharma, Inc. position peaked at $92K in Q1 2014.
- 175 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2021.
Based on Creative Planning's 13F filing for Q2 2021, filed 4 Aug 2021.